BIOLIFE SOLUTIONS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
BLFS$38.61+3.5%Stored close · as of Oct 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years Ended December 31 | |||
|---|---|---|---|
| (In thousands) | 2023 | 2022 | 2021 |
| Net loss | $(66,427) | $(139,805) | $(8,908) |
| Other comprehensive income (loss) - foreign currency translation adjustment, net of tax | 278 | (347) | (282) |
| Unrealized gain (loss) on available-for-sale securities, net of tax | 56 | (50) | - |
| Comprehensive loss | $(66,093) | $(140,202) | $(9,190) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.